Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells
出版年份 2020 全文链接
标题
Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells
作者
关键词
-
出版物
Cells
Volume 9, Issue 5, Pages 1140
出版商
MDPI AG
发表日期
2020-05-07
DOI
10.3390/cells9051140
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
- (2019) Juliane Günther et al. Frontiers in Immunology
- TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
- (2019) Doaa Tawfik et al. Frontiers in Immunology
- Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
- (2019) Soudabeh Rad Pour et al. Scientific Reports
- Bispecific antibodies enhance tumor‐infiltrating T cell cytotoxicity against autologous HER‐2‐expressing high‐grade ovarian tumors
- (2019) Hans‐Heinrich Oberg et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chemotherapy accelerates immune-senescence and functional impairments of Vδ2pos T cells in elderly patients affected by liver metastatic colorectal cancer
- (2019) Elena Bruni et al. Journal for ImmunoTherapy of Cancer
- Tumor-Repopulating Cells Induce PD-1 Expression in CD8 + T Cells by Transferring Kynurenine and AhR Activation
- (2018) Yuying Liu et al. CANCER CELL
- Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
- (2018) Anna Capsomidis et al. MOLECULAR THERAPY
- Single cell analysis of kynurenine and System L amino acid transport in T cells
- (2018) Linda V. Sinclair et al. Nature Communications
- Companies Scaling Back IDO1 Inhibitor Trials
- (2018) Cancer Discovery
- γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
- (2018) Elena Lo Presti et al. Frontiers in Immunology
- How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
- (2018) Alessandro Poggi et al. Frontiers in Immunology
- Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
- (2018) Alexander J. Muller et al. Seminars in Immunopathology
- Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
- (2018) Alessandro Poggi et al. Frontiers in Immunology
- Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
- (2018) Eric Fox et al. Frontiers in Oncology
- Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
- (2018) Emelie Rådestad et al. OncoImmunology
- The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
- (2017) Lieve Brochez et al. EUROPEAN JOURNAL OF CANCER
- Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor
- (2017) Benjamin J. Moyer et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy
- (2017) Christian Kellner et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity
- (2017) Guranda Chitadze et al. TRENDS IN IMMUNOLOGY
- Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
- (2017) S. Meraviglia et al. OncoImmunology
- IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
- (2017) Clément Barjon et al. OncoImmunology
- IFNγ Regulates Activated Vδ2+ T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem Cells
- (2017) Karoline Fechter et al. PLoS One
- γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
- (2016) Donnele Daley et al. CELL
- CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis
- (2016) Danay Cibrian et al. NATURE IMMUNOLOGY
- Erratum: CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis
- (2016) Danay Cibrian et al. NATURE IMMUNOLOGY
- Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients
- (2016) Hans-Heinrich Oberg et al. PANCREATOLOGY
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Epidemiology of pancreatic cancer
- (2016) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- γδ T cell activation by bispecific antibodies
- (2015) Hans-Heinrich Oberg et al. CELLULAR IMMUNOLOGY
- Bispecific antibodies
- (2015) Roland E. Kontermann et al. DRUG DISCOVERY TODAY
- The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment
- (2015) Johanna M Gostner et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
- (2015) Michael Platten et al. Frontiers in Immunology
- Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity
- (2015) Daniel Gonnermann et al. OncoImmunology
- Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
- (2015) Ulrike M. Litzenburger et al. Oncotarget
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition
- (2014) P. Mukherjee et al. JOURNAL OF IMMUNOLOGY
- L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression
- (2014) Evelin Grage-Griebenow et al. Molecular Oncology
- Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
- (2014) Ole Helm et al. PLoS One
- Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
- (2014) Hans-Heinrich Oberg et al. Frontiers in Immunology
- Plasticity of γδ T Cells: Impact on the Anti-Tumor Response
- (2014) Virginie Lafont et al. Frontiers in Immunology
- The stromal compartments in pancreatic cancer: Are there any therapeutic targets?
- (2013) Serena Lunardi et al. CANCER LETTERS
- Changing T-cell enigma: Cancer killing or cancer control?
- (2013) Thomas Wieder et al. CELL CYCLE
- Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
- (2013) Christian Peters et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma
- (2013) Simon M. Denley et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Nucleotide Specificity of DNA Binding of the Aryl Hydrocarbon Receptor:ARNT Complex Is Unaffected by Ligand Structure
- (2013) Danica E. DeGroot et al. TOXICOLOGICAL SCIENCES
- EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation
- (2012) Helena Kiefel et al. CARCINOGENESIS
- Using an Ancient Tool for Igniting and Propagating Immune Tolerance: IDO as an Inducer and Amplifier of Regulatory T Cell Functions
- (2012) F. Fallarino et al. CURRENT MEDICINAL CHEMISTRY
- Indoleamine 2,3-dioxygenase, Tregs and Cancer
- (2012) D. H. Munn CURRENT MEDICINAL CHEMISTRY
- The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
- (2012) A. Cesario et al. CURRENT MEDICINAL CHEMISTRY
- Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
- (2012) Lisa Leung et al. PLoS One
- Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
- (2012) Marco Donia et al. OncoImmunology
- Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
- (2011) Jonathan R. Brody et al. CELL CYCLE
- Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
- (2011) J. Godin-Ethier et al. CLINICAL CANCER RESEARCH
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
- (2011) Christiane A. Opitz et al. PLoS One
- TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT
- (2011) Najoua Lalaoui et al. PLoS One
- Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion
- (2010) Alexander J. Muller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
- (2010) J. D. Mezrich et al. JOURNAL OF IMMUNOLOGY
- Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma
- (2009) Hiroshi Urakawa et al. CLINICAL & EXPERIMENTAL METASTASIS
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
- (2009) Agnieszka K. Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection
- (2008) Agnes Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
- (2008) Marc Veldhoen et al. NATURE
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
- (2008) Francisco J. Quintana et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation